Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Apr 15 2026
Dec 2 2025
Oct 28 2025
May 19 2025
Mar 14 2026